pravastatin has been researched along with d-4f peptide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anantharamaiah, GM; Fogelman, AM; Frank, JS; Garber, DW; Hama, S; Handattu, S; Hough, G; Navab, M; Reddy, ST | 1 |
Banquerigo, ML; Brahn, E; Charles-Schoeman, C; Fogelman, AM; Hama, S; Navab, M; Park, GS; Van Lenten, BJ; Wagner, AC | 1 |
Anantharamaiah, GM; Fogelman, AM; Hama, S; Hough, G; Lehrer, RI; Navab, M; Palgunachari, MN; Ruchala, P; Waring, AJ | 1 |
Anantharamaiah, GM; Cao, D; Garber, DW; Handattu, SP; Kadish, I; Li, L; Monroe, CE; Nayyar, G; Palgunachari, MN; van Groen, T | 1 |
4 other study(ies) available for pravastatin and d-4f peptide
Article | Year |
---|---|
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.
Topics: Age Factors; Animal Feed; Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemotaxis, Leukocyte; Cholesterol, HDL; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Macaca fascicularis; Male; Mice; Mice, Mutant Strains; Monocytes; Pravastatin | 2005 |
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis.
Topics: Animals; Antibodies; Anticholesteremic Agents; Apolipoprotein A-I; Arthritis, Experimental; Arthritis, Rheumatoid; Chemotaxis; Cholesterol, HDL; Collagen Type II; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Histocytochemistry; Humans; Joints; Monocytes; Pravastatin; Radiography; Random Allocation; Rats; Regression Analysis | 2008 |
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Biological Availability; Female; Humans; Inflammation; Lipoproteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Mimicry; Niclosamide; Peptides; Pravastatin; Protein Structure, Secondary | 2009 |
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anticholesteremic Agents; Apolipoprotein A-I; Astrocytes; Chemokine CCL2; Cholesterol; Cognition; Disease Models, Animal; Drug Therapy, Combination; Hippocampus; Interleukin-1beta; Male; Maze Learning; Mice; Mice, Transgenic; Microglia; Plaque, Amyloid; Pravastatin; Protease Nexins; Receptors, Cell Surface; Tumor Necrosis Factor-alpha | 2009 |